Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Cytheris
Cytheris
Activities:
Manufacturing
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
OINDPs: Nosey about recent developments?
OINDPs are a user friendly and efficacious alternative to injectables in several disease areas
Transforming healthcare with patient centricity
In this opinion article, John Kytariolos, Head of Clinical and Scientific Affairs at Adragos Pharma, discusses patient-centric dosage forms, their properties and the impact...
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
Compact process thermostat for efficient temperature control in the laboratory
The temperature control system is designed for the accurate temperature control of small research reactors between -40 to +200 °C
AviadoBio expands presence at Canary Wharf
The company has acquired 11,000 sqft of laboratory and office space in Canary Wharf to accommodate the growing team
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Research & Development
Damian Marron joins Cytheris as chief executive
Will accelerate development of leading compound CYT107
Regulatory
Cytheris publish new oncology data
A second phase 1 trial in oncology has highlighted the potential for Interleukin-7
Regulatory
Laureate in agreement to manufacture lead product candidate for Cytheris
Laureate Pharma has entered into a cGMP contract manufacturing agreement with Cytheris
Regulatory
Cytheris initiates new trial in HIV patients
Cytheris to expand clinical trial programme for recombinant human Interleukin-7 - CYT107
Subscribe now